Several clinical studies have shown that there is a decline in naïve CD4+ T cells, as well as an imbalance of CD4+ Th cell subsets toward Th17 and Th22 pro-inflammatory subsets in obese individuals with T2D. The gene discussed is CD4; the disease is type 2 diabetes mellitus.